4.8 Article

Global analysis of protein folding using massively parallel design, synthesis, and testing

Journal

SCIENCE
Volume 357, Issue 6347, Pages 168-174

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aan0693

Keywords

-

Funding

  1. Howard Hughes Medical Institute
  2. Natural Sciences and Engineering Research Council of Canada
  3. AbbVie
  4. Bayer Pharma AG
  5. Boehringer Ingelheim
  6. Canada Foundation for Innovation
  7. Eshelman Institute for Innovation
  8. Genome Canada through Ontario Genomics Institute [OGI-055]
  9. Innovative Medicines Initiative (EU/EFPIA) through ULTRA-DD [115766]
  10. Janssen Pharmaceuticals
  11. Merck Co.
  12. Novartis Pharma AG
  13. Ontario Ministry of Research, Innovation and Science (MRIS)
  14. Pfizer
  15. Sao Paulo Research Foundation-FAPESP
  16. Takeda
  17. Wellcome Trust

Ask authors/readers for more resources

Proteins fold into unique native structures stabilized by thousands of weak interactions that collectively overcome the entropic cost of folding. Although these forces are encoded in the thousands of known protein structures, decoding them is challenging because of the complexity of natural proteins that have evolved for function, not stability. We combined computational protein design, next-generation gene synthesis, and a high-throughput protease susceptibility assay to measure folding and stability for more than 15,000 de novo designed miniproteins, 1000 natural proteins, 10,000 point mutants, and 30,000 negative control sequences. This analysis identified more than 2500 stable designed proteins in four basic folds-a number sufficient to enable us to systematically examine how sequence determines folding and stability in uncharted protein space. Iteration between design and experiment increased the design success rate from 6% to 47%, produced stable proteins unlike those found in nature for topologies where design was initially unsuccessful, and revealed subtle contributions to stability as designs became increasingly optimized. Our approach achieves the long-standing goal of a tight feedback cycle between computation and experiment and has the potential to transform computational protein design into a data-driven science.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available